Skip to main content
All articles

Site Operations

When sponsors don't provide equipment: the capital costs sites quietly absorb

By Julio G. Martinez-Clark Published November 6, 2026 Updated November 6, 2026 7 min read

Every site leader knows the moment. You win a study, start-up begins, someone reads the protocol closely, and a question stops the room: where is that machine coming from? The protocol assumes a specific electrocardiogram (ECG) device, a refrigerated centrifuge, a validated freezer, or an imaging capability. The sponsor is not providing it. No one budgeted for it. Because the clock is running, the site quietly buys, leases, or borrows its way out, absorbing a capital cost that should have been part of the study economics from the beginning.

The gap hides in the protocol, not in the budget

Equipment gaps rarely announce themselves. They hide in ordinary protocol language: samples processed within a stated window, ECG recordings transmitted to a central laboratory, study product stored within a defined temperature range, images uploaded in a specified format. Each sentence quietly assumes equipment, software, and staff time. If the sponsor provides the device, the assumption is harmless. If not, it becomes your purchase order.

At Amavita Research Services, our Miami cardiovascular trial site, we care for more than 18,000 active cardiology patients, and cardiovascular protocols are especially equipment-dependent. Central ECG requirements can turn on the exact device model, transmission method, and training certification, not simply on whether a site owns an ECG machine. A site can own a good device for clinical care and still lack the device the protocol requires. The gap is often not absence of equipment, but absence of the specified equipment, in the specified configuration, ready by the specified date. Our record of zero Food and Drug Administration (FDA) Form 483 findings did not come from improvising around those specifications, and I see the same lesson through bioaccess, a first-in-human (FIH) contract research organization (CRO). An equipment assumption not matched by a provision plan is an unfunded obligation for whoever signs last: usually, the site.

Spot it at feasibility, before you sign

Feasibility is your cheapest negotiating moment. Before signature, the sponsor wants your site, your principal investigator (PI), and your patients. After signature, the same request becomes a start-up problem you are expected to solve. Build an equipment cross-check into every feasibility review.

First, extract every equipment assumption from the protocol, the laboratory manual, the imaging manual, and the study-product handling instructions. List each required item: device, specification, software, consumables, calibration standard, and data-transfer method. Second, place that list beside the sponsor's provision list, line by line, instead of assuming they match. Third, mark each line: provided by the sponsor, already owned in the required configuration, or missing. Only the third category needs a decision, but it needs one immediately.

Ask direct questions while feasibility is still open. Who owns the device during the study? Who pays for installation, training, service, and replacement if it fails mid-study? What happens at study close? Are consumables and shipping included, or only the hardware? A vague assurance that the team will "work it out" is not an answer. Get the provision plan in writing, in the budget or a side letter, before the contract is final.

Buy, lease, or borrow: decide on total cost, not sticker price

Resist the fastest solution and run the total cost of ownership (TCO) comparison. TCO means every cost of having the equipment ready, compliant, and available for the study: acquisition or lease payments, delivery and installation, training, service, preventive maintenance, calibration, validation, consumables, software licenses, data-transfer fees, storage, insurance, and disposal. Then weigh residual value: can it serve other studies afterward?

Buying makes sense when the equipment is broadly useful across your pipeline, the study is long enough to justify ownership, and you can maintain it. Leasing makes sense when the requirement is study-specific, specifications change quickly, or you want service and replacement bundled into a predictable payment. Borrowing makes sense when a partner institution owns a compliant unit with genuine availability, provided the arrangement is written down, the device can be qualified for your use, and scheduling conflicts will not put a visit at risk.

Never compare purchase price against budget and stop there. A cheap device with expensive calibration, no local service, and a long repair timeline can cost more in missed visits and protocol deviations than a costly device with full support. Availability is part of cost: if the machine is down, windows are missed, and your site absorbs that damage too.

Negotiate it like a cost of the study, because it is

Equipment required by a protocol is a cost of conducting that study, and it belongs in the negotiation in plain language. Present the gap factually: the protocol requires this specification, the provision list does not include it, and the site does not own it in the required configuration. Then offer options instead of a complaint. The sponsor can provide the equipment, fund the purchase or lease as a distinct line item, agree on a per-use or per-procedure fee that recovers acquisition, maintenance, and consumables across expected volume, or adjust the start-up fee with the equipment cost identified inside it rather than buried.

Timing and specificity strengthen your position. Raise the item before signature, when budgets are still fluid, and tie it to start-up readiness: a funded site starts faster than one quietly shopping on its own credit. Name the device, the protocol section that requires it, and the full TCO figure. That is far harder to dismiss than a general claim that start-up is underfunded.

Negotiate the end at the beginning. Agree in writing who owns the equipment, who insures and maintains it, and what happens if the study closes or terminates early. If the site funds it, the agreement should avoid leaving you with a stranded asset for a study that never enrolled, the risk nobody mentions at feasibility and everybody remembers at close-out.

Qualify and document whatever lands on your floor

Your obligations begin when the equipment arrives. A device used in a trial needs documented evidence that it was installed correctly, operates as intended, and is maintained in that state. That means installation qualification (IQ), which confirms delivery and installation according to specifications and manufacturer requirements; operational qualification (OQ), which confirms correct operation across intended settings and ranges; and, where applicable, performance qualification, which confirms performance in actual use. Keep these records with the study documentation, not in a folder nobody can find during monitoring.

Documentation also includes the living records: calibration certificates, preventive maintenance logs, service and repair history, training records, and the standard operating procedure (SOP) that tells your team how the device is used, checked, and escalated when it fails. When a monitor asks how you know a freezer held temperature or a centrifuge performed to specification, "we bought a good one" is not evidence. The qualification file and maintenance trail are. Build them on day one, not months later from memory.

Track cost per study so the next negotiation starts from data

Finally, close the loop financially. Most sites can say what a study paid. Far fewer can say what it cost in equipment terms: allocated acquisition or lease charges, calibration and service, consumables, staff time on training and troubleshooting, and downtime. Track those figures per study in a simple register linking each item to the studies it served and what each contributed toward it.

That register makes the next TCO decision faster, because you work from history rather than estimates, and the next negotiation stronger, because documented costs start a different conversation than an opinion. It also reveals your pipeline economics: equipment serving many studies may be a bargain even at a high price, while a device bought for one protocol and never used again warns you to lease or negotiate provision next time.

The principle to keep

Do not let politeness make you the silent financier of someone else's protocol. Sponsors design studies, sites deliver them, and the equipment a design requires must be paid for openly and in advance. Spot the gap at feasibility. Decide on total cost, not urgency. Negotiate the line item before you sign. Qualify and document what you acquire. Track what each study truly cost you. That is not being difficult. It is being professional, and professionalism keeps a good site in business long enough to run the next study well.

Next step

Sponsors: see what Amavita Research can run

Amavita Research is a Miami cardiovascular trial site with 18,000+ active cardiology patients and zero United States Food and Drug Administration (FDA) Form 483 findings. See our site capabilities or talk with our sponsor team.

By Julio G. Martinez-Clark · Last updated November 6, 2026. This article is site-operations education and is not medical advice or a regulatory recommendation.

AI assistant, not a human. Please do not include health information.